Nautilus Biotechnology, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$2.58
+0.39%
Mkt Cap $331.60M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
-3.1%
Consensus $2.50 vs current $2.58
NASDAQ·Healthcare·Biotechnology
$2.58
+0.39%
Mkt Cap $331.60M
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
-3.1%
Consensus $2.50 vs current $2.58